Get started
Award

P01 AG025204

Funded outputs count: 218
Funder award ID: P01 AG025204
OpenAlex ID: G2453624921
Association of age with clinical progression across plasma p-tau217 levels
2026 · Ruyu Shi, Lamia T. Choity, et al. · medRxiv
PDF
Development of a Novel Blood‐Based Assay for Brain‐Derived Tau and Its Validation in Traumatic Brain Injury
2026 · Wasiu G. Balogun, Xuemei Zeng, et al. · Journal of Neurochemistry · 1
The dangers of data double dipping in assessing the classification accuracies of blood biomarkers in Alzheimer’s disease and related disorder research
2026 · Tianshu Liu, Xuemei Zeng, et al. · medRxiv
PDF
CNS-selective plasma p-tau217 accurately captures Alzheimer’s disease pathology and progression
2026 · Xuemei Zeng, Marissa F. Farinas, et al. · medRxiv · 2
PDF
Frequency of mixed neuropathologies in individuals with Down syndrome with and without Alzheimer's dementia
2026 · Lisi Flores-Aguilar, Thomas D. Zaikos, et al. · Acta Neuropathologica
PDF
2‐aminobutyrate mediates the impact of air pollution on blood biomarkers of Alzheimer's disease
2026 · Anum Saeed, Chris Mckennan, et al. · Alzheimer s & Dementia
Psychometric criteria for superior cognitive performance in very old adults
2026 · Michael Malek-Ahmadi, Sylvia E. Perez, et al. · Journal of Alzheimer s Disease
Plasma amyloid-β predicts amyloid-β accumulation in PET A- non-demented participants
2026 · Alexandra Gogola, Ann D. Cohen, et al. · Journal of Alzheimer s Disease · 2
Plasma brain-derived tau: analytical and clinical validation of the first commercial immunoassay
2026 · Michel N. Nafash, Sarah E. Svirsky, et al. · Scientific Reports · 7
PDF
The Alzheimer’s Pathways Sleep Study (ALPS): an experimental randomized controlled trial to improve cognition and Alzheimer’s pathophysiology through slow-wave sleep
2026 · Yue C. Dong, Rima F. Habte, et al. · Trials · 3
Head-to-head comparison of plasma p-tau217 immunoassays for incipient Alzheimer’s disease in community cohorts
2026 · Rebecca A. Deek, Wasiu G. Balogun, et al. · Alzheimer s Research & Therapy · 2
AI in geriatric psychiatry: precision meets human experience
2026 · Akiko Mizuno, Zackory Erickson, et al. · Neuropsychopharmacology · 1
PDF
Streamlined resource-efficient plasma amyloid-beta mass spectrometry assay has improved biomarker performance in preclinical Alzheimer’s disease
2026 · Yijun Chen, Xuemei Zeng, et al. · Nature Communications · 11
PDF
The Population Neuroscience-Dementia Syndemics Framework to better understand global sex and gender-based risk in low- and middle-income countries
2026 · C. Elizabeth Shaaban, Vidyani Suryadevara, et al. · Nature Aging · 4
PDF
Clarifying and extending permutation tests on brain map correspondence through mixed-effects modeling
2026 · Qiaochu Wang, Lingyi Peng, et al. · Imaging Neuroscience
Plasma p-tau212 identifies cognitively unimpaired individuals with emerging amyloid-β pathology
2025 · Przemysław R. Kac, Armand González-Escalante, et al. · Journal of Neurology · 3
PDF
Impact of cardiometabolic factors and AD plasma biomarkers on white matter hyperintensities volume in individuals with cognitive complaints from the global south
2025 · Patricio Riquelme-Contreras, Fernando Henriquez, et al. · Neuroscience · 1
PDF
Plasma biomarkers, brain amyloid‐beta pathology, and cortical thickness in a non‐Hispanic White and Black/African American middle‐aged community cohort: The HCP‐CoBRA study
2025 · Shayna T. Brodman, Nicholas Heaton, et al. · Alzheimer s & Dementia · 1
PDF
Cross‐cohort validation and cutpoint estimation of the Janssen plasma p‐tau217+ assay in predominantly cognitively normal community studies
2025 · Wasiu G. Balogun, Xuemei Zeng, et al. · Alzheimer s & Dementia · 2
PDF
Association Between the Genetic Risk for Attention-Deficit/Hyperactivity Disorder and Cognitive Function in Older Age: The MYHAT Population-Based Study
2025 · Douglas Teixeira Leffa, Yingjin Zhang, et al. · American Journal of Geriatric Psychiatry · 3
PDF
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community cohorts
2025 · Wasiu G. Balogun, Xuemei Zeng, et al. · medRxiv
PDF
Periventricular diffusivity reflects APOE ε4–modulated amyloid accumulation and cognitive impairment in the Alzheimer's disease continuum
2025 · Chang‐Le Chen, Sang Joon Son, et al. · Alzheimer s & Dementia · 11
Bridging Neuroimaging and Neuropathology: A Comprehensive Workflow for Targeted Sampling of White Matter Lesions
2025 · Nadim Farhat, Jinghang Li, et al. · Journal of Neuroimaging
CSF total tau as a proxy of synaptic degeneration
2025 · Carolina Soares, Bruna Bellaver, et al. · Nature Communications · 15
PDF
Rest‐Activity Rhythms and Cognition in Older Adults With and Without Insomnia
2025 · Miranda G. Chappel‐Farley, Zhiwei Zhao, et al. · Journal of Sleep Research
PDF
Year
Topic